Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

Raven Myrick, MSN, CRNP, Brandi Pernell, DNP, Avi Madan-Swain, PhD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO, MSPH

Blood (2019) 134 (Supplement_1): 4691.

https://doi.org/10.1182/blood-2019-131059

Published: 2019

Journal Articles

The Impact of Different Pediatric Estimated GFR Equations on Reporting of Renal Outcomes

Jeffrey D. Lebensburger, DO, MSPH, Shreya Saxena, Jeanine Dumas, Daniel Feig, MD, Julie Kanter, MD

Blood (2019) 134 (Supplement_1): 2311.

https://doi.org/10.1182/blood-2019-131606

Published: 2019

Journal Articles

Safety and Efficacy of Liposomal Cytarabine/Daunorubicin (CPX-351) in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia

Amanda Przespolewski, Chetasi Talati, MD, Pankit Vachhani, MD, Srinivasa Reddy Sanikommu, MD, Swapna Thota, MD, Jeffrey Baron, PharmD, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Kendra L. Sweet, MD, Eunice S. Wang, MD

Blood (2018) 132 (Supplement 1): 2677.

https://doi.org/10.1182/blood-2018-99-113002

Published: 2018

Journal Articles

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Gloria Contreras-Yametti, MD, Custodio Haidee, MD, Hamayun Imran, MD MSc

Blood (2018) 132 (Supplement 1): 3665.

https://doi.org/10.1182/blood-2018-99-111362

Published: 2018

Journal Articles

Active and Ultra-Large Von Willebrand Factor Is Significantly Elevated in Patients with Immune Thrombotic Thrombocytopenic Purpura

Wenjing Cao, PhD, Alicia Veninga, M.Sc., Elizabeth M. Staley, MD, PhD, Adam Miszta, PhD, Nicole Kocher, B.Sc., Lance Williams, III, MD, Marisa B. Marques, MD, Bas de Laat, MD, PhD, X. Long Zheng, MD PhD

Blood (2018) 132 (Supplement 1): 523.

https://doi.org/10.1182/blood-2018-99-117647

Published: 2018

Journal Articles

Familial Polycythemia Likely Due to Novel Hemoglobin Variant Hemoglobin Hyden

Sandhya Kolagatla, Nagabhishek Moka, MD, Samuel D. Bailey, MD

Blood (2018) 132 (Supplement 1): 4925.

https://doi.org/10.1182/blood-2018-99-119590

Published: 2018

Journal Articles

Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study

Blood (2017) 130 (Supplement 1): 725.

https://doi.org/10.1182/blood.V130.Suppl_1.725.725

Published: 2017

Journal Articles

Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study

Blood (2017) 130 (Supplement 1): 2579.

https://doi.org/10.1182/blood.V130.Suppl_1.2579.2579

Published: 2017

Journal Articles

Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Ellen K Ritchie, MD, Rosalind Catchatourian, MD, Rebecca B. Klisovic, MD, Javier Pinilla-Ibarz, MD PhD, Michael W. Deininger, MD PhD, Harry P. Erba, MD PhD, Jerald P. Radich, MD, Michael R. Savona, MD, Ilva Dautaj, MS, Das Purkayastha, Karen Habucky, PhD, Michael J. Mauro, MD

Blood (2017) 130 (Supplement 1): 2875.

https://doi.org/10.1182/blood.V130.Suppl_1.2875.2875

Published: 2017

Journal Articles

Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow

Omer Jamy, Sejong Bae, Luciano J. Costa, MD PhD, Harry P. Erba, MD PhD, Nikolaos Papadantonakis, MD MSc

Blood (2017) 130 (Supplement 1): 3871.

https://doi.org/10.1182/blood.V130.Suppl_1.3871.3871

Published: 2017

Journal Articles

Decline in Late Mortality after Allogeneic Blood or Marrow Transplantation (alloBMT) Performed in Childhood: a Report from the BMT Survivor Study-2 (BMTSS-2)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Michelle Kung, MA, Emily Ness, MPH, Kevin D. Battles, BS, Ravi Bhatia, MD, Donna Salzman, MD, Jeanette Falck Winther, MD DMSc, Stephen J. Forman, MD, Joseph Rosenthal, MD MS, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 672.

https://doi.org/10.1182/blood.V130.Suppl_1.672.672

Published: 2017

Journal Articles

IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Jorge E. Cortes, MD, Elie Traer, MD PhD, Eunice S. Wang, MD, Harry P. Erba, MD PhD, William Blum, MD, Cecilia Arana-Yi, MD, Callum M. Sloss, Kerry Culm-Merdek, Jeanette Towles, Patrick A. Zweidler-McKay, MDPhD, Daniel J. DeAngelo, MD

Blood (2017) 130 (Supplement 1): 1312.

https://doi.org/10.1182/blood.V130.Suppl_1.1312.1312

Published: 2017

Journal Articles

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Anna Sallfors Holmqvist, MD PhD, Yanjun Chen, MS, Jessica Wu, BA, Lindsey Hageman, MPH, Liton F. Francisco, BS, Mariel Parman, MPH, Michelle Kung, MA, Emily Ness, MPH, Kevin D. Battles, BS, Jeanette Falck Winther, MD DMSc, Joseph Rosenthal, MD MS, Ravi Bhatia, MD, Donna Salzman, MD, Stephen J. Forman, MD FACP, Daniel J. Weisdorf, MD, Saro H. Armenian, DO,MPH, Mukta Arora, MD, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 337.

https://doi.org/10.1182/blood.V130.Suppl_1.337.337

Published: 2017

Journal Articles

Beliefs and Patterns of Practice in the Management of Hyperleukocytosis and Leukostasis Among Health Care Providers for Patients with Acute Leukemia: A Large North American Web-Based Survey

Maximilian Stahl, MD, Alexander Pine, MD PhD, Jeanne E. Hendrickson, MD, Mark R. Litzow, MD, Selina Luger, MD FRCPC, Richard M. Stone, MD, Harry P. Erba, MD PhD, Tae Kon Kim, MD PhD, Mikkael A. Sekeres, MD MS, David P. Steensma, MD, Rami S. Komrokji, MD, Steven D. Gore, MD, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 1129.

https://doi.org/10.1182/blood.V130.Suppl_1.1129.1129

Published: 2017

Journal Articles

Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data

Megan Othus, PhD, Guillermo Garcia-Manero, MD, John Godwin, MD, James K. Weick, MD, Jeanne E. Anderson, MD, Derek Stirewalt, MD, Frederick R. Appelbaum, MD, Harry P. Erba, MD PhD, Elihu H. Estey, MD

Blood (2017) 130 (Supplement 1): 1301.

https://doi.org/10.1182/blood.V130.Suppl_1.1301.1301

Published: 2017

Journal Articles

Therapy Preference and Outcomes of Hydroxyurea for Pediatric Patients with Silent Cerebral Infarcts

Tullia Rushton, BS, Inmaculada Aban, PhD, Daniel Young, MD, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 3531.

https://doi.org/10.1182/blood.V128.22.3531.3531

Published: 2016

Journal Articles

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

Orlando Esparza, MD, Ana Xavier, MD, Matthew A. Kutny, MD, Julie A. Wolfson, MD, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 2385.

https://doi.org/10.1182/blood.V128.22.2385.2385

Published: 2016

Journal Articles

EZH2 Upregulation Is Associated with Unfavorable Prognosis in Diffuse Large B-Cell Lymphoma through Potential RUNX3 Downregulation

Denise Peker, MD, Samara Roman-Holba, Yuri Kwon, Jennifer Gordetsky, Amitkumar Mehta, MD, Andres Forero, Luciano J. Costa, MD PhD, Vishnu Reddy, MD, Yang Yang, Balabhadrapatruni VSK Chakravarthi, Sooryanarayana Varambally, PhD

Blood (2016) 128 (22): 5301.

https://doi.org/10.1182/blood.V128.22.5301.5301

Published: 2016

Journal Articles

Acute Kidney Injury during Pediatric Vaso-Occlusive Crisis

Sujatha Baddam, MBBS, Inmaculada Aban, PhD, Daniel Feig, MD PhD MS, Lee Hilliard, MD, David Askenazi, MDMSPH, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 3669.

https://doi.org/10.1182/blood.V128.22.3669.3669

Published: 2016

Journal Articles

Outcomes of Fever in Infants and Young Children with SCD Presenting to the Emergency Room

Krishnaveni Sirigaddi, MBBS, Inmaculada Aban, PhD, Christina J. Bemrich-Stolz, MDMSPH, Thomas H. Howard, MD, Lee Hilliard, MD, Jeffrey D. Lebensburger, DO MSPH

Blood (2016) 128 (22): 3591.

https://doi.org/10.1182/blood.V128.22.3591.3591

Published: 2016

NARROW

Impact of a Pediatric Sickle Cell Outpatient Pain Clinic on Health Outcomes

The Impact of Different Pediatric Estimated GFR Equations on Reporting of Renal Outcomes

Safety and Efficacy of Liposomal Cytarabine/Daunorubicin (CPX-351) in Younger Patients < 60 Years Old with Secondary Acute Myeloid Leukemia

Prevalence of Severe Bacterial Infection in Febrile Children with Sickle CELL Disease in the Era of Pneumococcal Conjugate Vaccine 13

Active and Ultra-Large Von Willebrand Factor Is Significantly Elevated in Patients with Immune Thrombotic Thrombocytopenic Purpura

Familial Polycythemia Likely Due to Novel Hemoglobin Variant Hemoglobin Hyden

Ivosidenib (AG-120) in Mutant IDH1 AML and Advanced Hematologic Malignancies: Results of a Phase 1 Dose Escalation and Expansion Study

Prospective Study of Acute Myeloid Leukemia (AML) Clinical Epidemiology and Cytogenetic Risk Group in Older Adults in the ECOG-ACRIN E2906 Clinical Trial: The Acute Leukemia Epidemiology, Survival and Endpoints (ALESE) Study

Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Favorable Outcomes with Fludarabine, High Dose Cytarabine and Granulocyte Colony Stimulating Factor (FLAG) As Re-Induction for Residual Acute Myeloid Leukemia on Day 14 Bone Marrow

Decline in Late Mortality after Allogeneic Blood or Marrow Transplantation (alloBMT) Performed in Childhood: a Report from the BMT Survivor Study-2 (BMTSS-2)

IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Reduction in Late Mortality after Autologous Blood or Marrow Transplantation (autoBMT) in Childhood - a Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)

Beliefs and Patterns of Practice in the Management of Hyperleukocytosis and Leukostasis Among Health Care Providers for Patients with Acute Leukemia: A Large North American Web-Based Survey

Associations between Complete Remissions (CRs) with 7+3 Induction Chemotherapy for Acute Myeloid Leukemia and 2-3 Year Survival ("Potential Cure") over the Past Four Decades: Analysis of SWOG Trial Data

Therapy Preference and Outcomes of Hydroxyurea for Pediatric Patients with Silent Cerebral Infarcts

Malignancy Risk Markers in a Cohort of Referrals for Lymphadenopathy; An Evaluation of Clinical Features Including Lymph Node Size

EZH2 Upregulation Is Associated with Unfavorable Prognosis in Diffuse Large B-Cell Lymphoma through Potential RUNX3 Downregulation

Acute Kidney Injury during Pediatric Vaso-Occlusive Crisis

Outcomes of Fever in Infants and Young Children with SCD Presenting to the Emergency Room

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only